PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3535012-5	1986	Enhancement of PP and CCK secretion was almost completely abolished by pretreatment with 1 mg atropine.	Atropine	94-102	familial progressive hyperpigmentation 1	Homo sapiens	15-17	
3544336-5	1986	Atropine diminished the cisapride-induced hPP elevation, thereby suggesting that cisapride induced release of acetylcholine but had no antidopaminergic action.	Atropine	0-8	familial progressive hyperpigmentation 1	Homo sapiens	42-45	
6848897-1	1983	The effect of atropine, a muscarinic cholinergic blocking agent, on the response of plasma pancreatic polypeptide (hPP) to the ingestion of beef was investigated.	Atropine	14-22	familial progressive hyperpigmentation 1	Homo sapiens	115-118	
6848897-6	1983	Mean integrated incremental hPP responses in the absence of atropine were 9.1 +/- 3.4 ng min ml-1 for the first phase (0-40 min) and 29.7 +/- 5.7 ng min ml-1 for the second phase (60-180 min); with atropine at 4 min, respective responses were 0.8 +/- 0.9 and -1.0 +/- 1.3 ng min ml,-1 and with atropine at 60 min they were 10.6 +/- 5.0 and 1.3 +/- 1.6 ng min ml.-1 After atropine administration, the half-time of disappearance of hPP from the circulation was 4-6 min, suggesting the complete cessation of stimulated hPP secretion.	Atropine	198-206	familial progressive hyperpigmentation 1	Homo sapiens	28-31	
6848897-6	1983	Mean integrated incremental hPP responses in the absence of atropine were 9.1 +/- 3.4 ng min ml-1 for the first phase (0-40 min) and 29.7 +/- 5.7 ng min ml-1 for the second phase (60-180 min); with atropine at 4 min, respective responses were 0.8 +/- 0.9 and -1.0 +/- 1.3 ng min ml,-1 and with atropine at 60 min they were 10.6 +/- 5.0 and 1.3 +/- 1.6 ng min ml.-1 After atropine administration, the half-time of disappearance of hPP from the circulation was 4-6 min, suggesting the complete cessation of stimulated hPP secretion.	Atropine	198-206	familial progressive hyperpigmentation 1	Homo sapiens	28-31	
6848897-6	1983	Mean integrated incremental hPP responses in the absence of atropine were 9.1 +/- 3.4 ng min ml-1 for the first phase (0-40 min) and 29.7 +/- 5.7 ng min ml-1 for the second phase (60-180 min); with atropine at 4 min, respective responses were 0.8 +/- 0.9 and -1.0 +/- 1.3 ng min ml,-1 and with atropine at 60 min they were 10.6 +/- 5.0 and 1.3 +/- 1.6 ng min ml.-1 After atropine administration, the half-time of disappearance of hPP from the circulation was 4-6 min, suggesting the complete cessation of stimulated hPP secretion.	Atropine	198-206	familial progressive hyperpigmentation 1	Homo sapiens	28-31	
449693-4	1979	Atropine pretreatment in five male control subjects significantly decreased basal hPP levels and completely abolished the response to MET.	Atropine	0-8	familial progressive hyperpigmentation 1	Homo sapiens	82-85	
7047252-11	1982	3) Under the above conditions, the hPP response to hypoglycemia can be blocked by atropine, thus indicating that it is due to activation of the cholinergic system and not to the direct effect of glucose lack at the level of the hPP-cell.	Atropine	82-90	familial progressive hyperpigmentation 1	Homo sapiens	35-38	
7047252-11	1982	3) Under the above conditions, the hPP response to hypoglycemia can be blocked by atropine, thus indicating that it is due to activation of the cholinergic system and not to the direct effect of glucose lack at the level of the hPP-cell.	Atropine	82-90	familial progressive hyperpigmentation 1	Homo sapiens	228-231	
6997131-5	1980	Phentolamine alone caused a twofold rise in hPP concentration, which was abolished by simultaneous atropine infusion.	Atropine	99-107	familial progressive hyperpigmentation 1	Homo sapiens	44-47	
12452381-10	2002	There was a significant decrease in serum PP after intravenous atropine.	Atropine	63-71	familial progressive hyperpigmentation 1	Homo sapiens	42-44	
400718-7	1978	In contrast, prior injection of atropine (1 mg iv) lowered basal hPP levels and reduced conspicuously the hPP response to 2-DG.	Atropine	32-40	familial progressive hyperpigmentation 1	Homo sapiens	65-68	
400718-7	1978	In contrast, prior injection of atropine (1 mg iv) lowered basal hPP levels and reduced conspicuously the hPP response to 2-DG.	Atropine	32-40	familial progressive hyperpigmentation 1	Homo sapiens	106-109	
9802413-5	1998	Atropine did not inhibit the contractions to NPY, PYY and [Leu31,Pro34]NPY but significantly affected those to NPY(13-36), [D-Trp32]NPY, rPP and hPP.	Atropine	0-8	familial progressive hyperpigmentation 1	Homo sapiens	145-148